Forssell-Aronsson E - Search Results

1

Biodistribution data from 100 patients i.v. injected with 111In-DTPA-D-Phe1-octreotide.

Forssell-Aronsson E, Bernhardt P, Nilsson O, Tisell LE, Wängberg B, Ahlman H. Forssell-Aronsson E, et al. Acta Oncol. 2004;43(5):436-42. doi: 10.1080/02841860410030670. Acta Oncol. 2004. PMID: 15360047

2

Comparison of seven iodine-labelled monoclonal antibodies in nude mice with human colon carcinoma xenografts.

Forssell Aronsson E, Grétarsdóttir J, Jacobsson L, Mattsson S, Holmberg SB, Hafström LO, Karlsson B, Lindholm L. Forssell Aronsson E, et al. Acta Oncol. 1991;30(3):385-93. doi: 10.3109/02841869109092391. Acta Oncol. 1991. PMID: 2036251

3

Somatostatin receptors on neuroendocrine tumors--a way to intraoperative diagnosis and localization.

Ahlman H, Tisell LE, Wängberg B, Nilsson O, Fjälling M, Forssell-Aronsson E. Ahlman H, et al. Yale J Biol Med. 1994 May-Aug;67(3-4):215-21. Yale J Biol Med. 1994. PMID: 7502530 Free PMC article.

4

Indium-111 activity concentration in tissue samples after intravenous injection of indium-111-DTPA-D-Phe-1-octreotide.

Forssell-Aronsson E, Fjälling M, Nilsson O, Tisell LE, Wängberg B, Ahlman H. Forssell-Aronsson E, et al. J Nucl Med. 1995 Jan;36(1):7-12. J Nucl Med. 1995. PMID: 7799086 Free article.

5

Clinical efficacy of octreotide scintigraphy in patients with midgut carcinoid tumours and evaluation of intraoperative scintillation detection.

Ahlman H, Wängberg B, Tisell LE, Nilsson O, Fjälling M, Forssell-Aronsson E. Ahlman H, et al. Br J Surg. 1994 Aug;81(8):1144-9. doi: 10.1002/bjs.1800810820. Br J Surg. 1994. PMID: 7953343

6

Somatostatin receptor imaging in patients with neuroendocrine tumors: preoperative and postoperative scintigraphy and intraoperative use of a scintillation detector.

Ahlman H, Tisell LE, Wängberg B, Nilsson O, Forssell-Aronsson E, Fjälling M. Ahlman H, et al. Semin Oncol. 1994 Oct;21(5 Suppl 13):21-8. Semin Oncol. 1994. PMID: 7992076 No abstract available.

7

Intraoperative detection of somatostatin-receptor-positive neuroendocrine tumours using indium-111-labelled DTPA-D-Phe1-octreotide.

Wangberg B, Forssell-Aronsson E, Tisell LE, Nilsson O, Fjalling M, Ahlman H. Wangberg B, et al. Br J Cancer. 1996 Mar;73(6):770-5. doi: 10.1038/bjc.1996.134. Br J Cancer. 1996. PMID: 8611378 Free PMC article. Clinical Trial.

8

Systemic radionuclide therapy using indium-111-DTPA-D-Phe1-octreotide in midgut carcinoid syndrome.

Fjälling M, Andersson P, Forssell-Aronsson E, Grétarsdóttir J, Johansson V, Tisell LE, Wängberg B, Nilsson O, Berg G, Michanek A, Lindstedt G, Ahlman H. Fjälling M, et al. J Nucl Med. 1996 Sep;37(9):1519-21. J Nucl Med. 1996. PMID: 8790206 Free article.

9

[Glucagonoma. A tumor disease with multiple clinical manifestations].

Andersson K, Wängberg B, Tisell LE, Nilsson O, Fjälling M, Forssell-Aronsson E, Ahrén B, Ahlman H. Andersson K, et al. Lakartidningen. 1996 Aug 28;93(35):2935-9. Lakartidningen. 1996. PMID: 8815353 Swedish.

10

Internalization of indium-111 into human neuroendocrine tumor cells after incubation with indium-111-DTPA-D-Phe1-octreotide.

Andersson P, Forssell-Aronsson E, Johanson V, Wängberg B, Nilsson O, Fjälling M, Ahlman H. Andersson P, et al. J Nucl Med. 1996 Dec;37(12):2002-6. J Nucl Med. 1996. PMID: 8970523 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

192 results

Search Page

Filters